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E-mail address: farzana58@uum.edu.my (F.K. AhmUnderstanding the mechanisms of gene regulation during breast cancer is one of the most difﬁcult prob-
lems among oncologists because this regulation is likely comprised of complex genetic interactions.
Given this complexity, a computational study using the Bayesian network technique has been employed
to construct a gene regulatory network from microarray data. Although the Bayesian network has been
notiﬁed as a prominent method to infer gene regulatory processes, learning the Bayesian network struc-
ture is NP hard and computationally intricate. Therefore, we propose a novel inference method based on
low-order conditional independence that extends to the case of the Bayesian network to deal with a large
number of genes and an insufﬁcient sample size. This method has been evaluated and compared with
full-order conditional independence and different prognostic indices on a publicly available breast cancer
data set. Our results suggest that the low-order conditional independence method will be able to handle a
large number of genes in a small sample size with the least mean square error. In addition, this proposed
method performs signiﬁcantly better than other methods, including the full-order conditional indepen-
dence and the St. Gallen consensus criteria. The proposed method achieved an area under the ROC curve
of 0.79203, whereas the full-order conditional independence and the St. Gallen consensus criteria
obtained 0.76438 and 0.73810, respectively. Furthermore, our empirical evaluation using the low-order
conditional independence method has demonstrated a promising relationship between six gene
regulators and two regulated genes and will be further investigated as potential breast cancer metastasis
prognostic markers.
Published by Elsevier Inc.1. Introduction
Distant metastasis is one of the main causes of death among
breast cancer patients [1]. The National Cancer Institute (NCI) esti-
mated that 40% of breast cancer patients relapse and develop met-
astatic disease, and about 40,000 women die of metastatic breast
cancer every year. Despite signiﬁcant advances in the treatment
of breast cancer, the ability to describe the metastatic behavior
of tumors remains the utmost clinical challenge in oncology.
Although clinical and pathological factors such as tumor size,
grade, patient age and hormone receptor status could be used to
predict the likelihood of metastasis in typical breast cancer pa-
tients, for a majority of patients with intermediate-risk of breast
cancer these factors appear to be less beneﬁcial. Accordingly,
approximately 70–80% of lymph node-negative patients may un-
dergo adjuvant chemotherapy or hormonal therapy which tends
to be unnecessary. Moreover, it is believed that many of the cur-
rent risk factors are likely to be secondary manifestations rather
than primary mechanisms of the disease. Ideally, we would likeInc.
ad).to investigate the gene regulatory process that triggers breast can-
cer metastasis.
The emergence of DNA microarray technologies over the past
decade has modernized the approach of biological research in such
a way that scientists can now measure the expression levels of
thousands of genes simultaneously. These high-throughput exper-
imental data have allowed for recent research to discover complex
interactions between genes. Regulatory mechanisms promote
proper genetic interactions throughout life that maintain health
and are perturbed during the initiation of cancers and other dis-
eases. Therefore, one of the most signiﬁcant insights into cancer
biology in recent years has been the inference of a gene regulatory
network (GRN) to identify new prognostic markers that are more
directly related to disease and to highlight genetic interactions that
can more accurately predict the risk of metastasis in individual
patients.
GRN refers to a set of molecular components, including genes,
proteins and other molecules, as well as the interactions between
these molecules that collectively carry out a cellular function.
The fundamental idea behind GRN analysis is to extract pro-
nounced gene regulatory features (e.g., regulator gene) by examin-
ing gene expression patterns. It is known that some genes regulate
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certain time could activate or inhibit the expression of another
gene. Thus, the regulation of gene expression has an important role
in cellular functions. Changes in the expression levels of particular
genes across a whole process, such as the cell cycle or response to
certain treatments, have provided information that allow for re-
verse engineering techniques to construct a network of genetic
regulatory relations. Several studies have reported that these
learned networks have the potential to assist researchers in sug-
gesting and evaluating new hypotheses in the context of genetic
regulatory processes [2,3]. Such data-driven regulatory network
analysis would eventually lead to a better understanding of the
complex genetic regulatory processes, which has important impli-
cations in the pharmaceutical industry and many other biomedical
ﬁelds. Thus, identifying GRNs and understanding regulatory pro-
cesses at the genetic level has become an imperative goal in com-
putational biology.
Multiple components are involved in regulatory networks at the
pathological level of cancer [4]. The development of diagnosismeth-
ods, the selection of gene therapy candidates, and the elucidation of
drug targets will be improved since the dissection of regulatory net-
works couldpresent abetterunderstandingof themechanismof this
disease. For example, strategies to discover new cancer drugs has
shifted from ﬁnding chemicals that kill tumor cells toward identify-
ingmolecular targets that underlie cell transformation [5]. The latter
approach relies on a deeper mechanistic understanding of the regu-
latoryprocessesandholdspromiseofdiscoveringmoreeffectiveand
safer drugs. GRN analysis, although not directly providing the drug
target, provides new insights and hypotheses in understanding the
mechanismof gene regulationpathwaysandultimately in achieving
a holistic understanding of the genetic regulatory process. GRN also
provides the foundation to establish new applications for the treat-
ment of genetic disease and drug design.
Various mathematical and computational methods have been
employed in previous studies for modeling GRN from microarray
data, including Boolean networks, pair-wise comparison [6,7], dif-
ferential equations estimation [8], Bayesian networks [9,10], ARAC-
NE [70,71] and other techniques. Among these, the Bayesian
network models attract the most attention and have been the more
prominent techniques because they are able to capture linear, non-
linear, combinatorial, stochastic and casual relationships between
variables. Compared to other methods that only compute pair-wise
statistical strengths between two genes, Bayesian network models
offer considerable relationships between all genes in the system. In
addition, due to rich probabilistic semantics, this model is also
capable of working with noisy data a common problem with
microarray data. Furthermore, this technique allows for different
implicit variable information to be added to the networks, which
possibly enhances the interpretation of the gene regulation pro-
cess. Thus, Bayesian network has been employed in this study to
analyze gene regulatory processes and to model gene relationships
during breast cancer metastasis.
The key challenge in using Bayesian networks to infer GRN is
that the structure learning of the Bayesian network is NP-hard
and computationally complex, as the number of possible graphs in-
creases super-exponentially with the number of genes and an
exhaustive search is untraceable. This difﬁculty is a common prob-
lem in gene regulatory analysis because only a relatively small
number of measurements are included into the network. The prob-
lem is mainly due to the high dimensionality of microarray data,
which usually contain an insufﬁcient sample measurement or large
number of genes, needed to capture the complex interactions of
biological systems. On the other hand, the knowledge of the overall
structures of gene networks has been invaluable toward a com-
plete mechanistic understanding about the complex roles of indi-
vidual genes and their interactions [11].In recent years, several inference methods have been proposed
to estimate the topology of the directed acyclic graph (DAG) and to
address the issue of structure learning in Bayesian networks to
construct a GRN. To name a few, Beal et al. [12] developed a vari-
ational Bayesian model, while Yavari et al. [13] used cross-correla-
tion between different gene pairs. There are also numerous studies
that have used scoring metric techniques, for example Bayesian
Information Criterion (BIC), Bayesian Dirichlet equivalent (BDe)
and Akaike’s information criterion (AIC) with heuristic search
methods, to address this problem [14–16]. Software like BANJO
has been used to estimate the topology of Bayesian network struc-
ture. However, these approaches suffer from several drawbacks be-
cause they cannot provide us with posterior distributions over all
the parameters of the model that are needed to quantify our uncer-
tainty. This indicates that those approaches do not offer a mecha-
nism to represent posterior distributions over model parameters
and, therefore, are unable to elucidate the sort of gene–gene inter-
actions that we are interested in examining. Furthermore, heuristic
search methods are not computationally efﬁcient and a relatively
low accuracy of learned structures may be observed. In addition,
most GRN studies are interested in achieving a high prediction
accuracy without revealing the importance of biological informa-
tion, which is essential in understanding the disease [17]. Thus,
the potential impact of gene expression proﬁling in cancer diagno-
sis, prognosis and in the development of personalized treatment
may not be fully exploited due to the lack of consensus with infer-
ence networks and a poor understanding of the underlying molec-
ular mechanisms.
In this paper, we seek to infer breast cancer metastasis with
improved structure learning of Bayesian networks using a GRN.
Our intention is to identify the genetic regulators that are related
to breast cancer metastasis and to highlight genes interaction
processes that can precisely predict the risk of relapse. We
accomplished this by inferring breast cancer expression data using
low-order conditional independence to the extent of the Bayesian
network. This technique is appropriate for use because it is capable
of handling data sets with a small sample size. We also evaluated
three variants of these methods: low-order conditional indepen-
dence, full-order conditional independence and the established
breast cancer treatment guideline, which is known as St. Gallen
consensus using Receiver Operating Characteristic (ROC) curves on
the public breast cancer data set. These results demonstrate that
the GRN using low-order conditional independence with the
Bayesian network does lead to improved inference of breast cancer
metastasis over other methods.
2. Related works
The main purpose of the GRN analysis is to identify regulatory
relationships among the immense number of genes that form a net-
work representation of the underlying regulatory processes. In such
an analysis, gene interactions are viewed as signaling processes that
create a complex feedback network. The construction and mainte-
nance of information for this signaling system is stored in the gen-
ome. DNA sequence encodes the structure and the molecular
dynamics of RNA, which encode the proteins that in turn determine
the biochemical recognition of the signaling processes [18]. The
regulatory molecules that control gene expression are themselves
products of other genes. Generally, genes turn each other on and
off within a proximal genetic network of transcriptional regulators
[19] that provide a partial picture of the complex biological pro-
cesses. Many other factors such as proteins and metabolites, which
also play important roles in this signaling system, are not easily de-
tected. Hence, a genetic network that summarizes aggregated ef-
fects reﬂected in gene expression patterns still reveals insufﬁcient
valuable information about the underlying processes.
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ships is the ‘‘knockout’’ experiment, in which the expression levels
of a particular gene is decreased while all other conditions are kept
constant. Differences in gene expression levels of other genes infer
underlying regulatory relations. Usually, this approach can reliably
uncover regulatory relationships among a small number of genes,
but this approach cannot be scaled up to study regulatory net-
works consisting of hundreds of genes due to the sheer number
of experimental manipulations needed to reveal a complete regu-
latory network. A recent development in microarray technologies
has made it possible to routinely measure the expression levels
of tens or hundreds of thousands of genes simultaneously. Such a
development has enabled researchers to apply reverse engineering
approaches towards observational expression data to identify
large-scale gene regulatory network structures.
The earliest proposed models for learning gene regulatory net-
works from microarray data were discrete models. Several studies
proposed the construction of Boolean regulatory networks in which
the gene expression levels were represented as 0 (not expressed) or
1 (expressed) [20]. These models are based on the assumption that
biological networks can be represented by binary, synchronously-
updating switching networks. However, large amounts of informa-
tion might be lost during binary discretization. Many continuous
models have been proposed recently to fully utilize the information
contained in gene expression data. Wessels et al. [8] categorized
existing continuous models of gene regulatory networks into
pair-wise networks and weighted-sum networks. Pair-wise net-
works are constructed with pair-wise comparison methods based
on the relationships between pairs of genes. Two examples of such
methods are the Correlation Metric Construction (CMC) [6] and the
Activation/Inhibition Networks [7]. In addition, ARACNE is another
approach that used to construct GRN [70,71]. However, this ap-
proach relies on different methodology. In general, ARACNE is
developed using information-theoretic algorithm and could pro-
duce different topology. Like CMC and the Activation/Inhibition
Networks, this network is based on pair wise similarity only, and
thusmaymiss interaction betweenmultiple genes [70,71]. Further-
more, these approaches ignore the fact that the expression level of
one gene is governed by the combined actions of multiple genes
and thus cannot reveal a complete regulatory structure.
Weighted-sum network models represent gene expression lev-
els as a weighted sum of the upstream gene expression levels.
Wessels et al. [8] used a generalized differential or difference equa-
tion (the difference equation is shown in (1)) to characterize this
class of models:
Xi½t þ 1 ¼ Ri  g
XJ
J¼1
Wij:Xj½t þ
XK
k¼1
Vik:Uk þ Bi
 !
 ki:Xi½t ð1Þ
with the subsequent biological meaning: g refers to the regulation-
expression (activation) function; Xi [t] represents the expression of
gene i at time instance t; Ri symbolizes the rate constant of gene i;
Wij represents the strength of inﬂuence of gene j on gene i; Uk[t] rep-
resents kth external input at time instance t; Vik represents the
inﬂuence of the kth external input on gene i; Bi represents the base
expression level of gene i, and kirepresents the degradation constant
of gene i.
A variety of approaches have been proposed to estimate the
parameters of these differential or difference equations, including
Recurrent Hopﬁeld networks [21], linear programming [7], simu-
lated annealing [22], genetic algorithms [23] and linear regression
[24].When a large number of genes are incorporated into themodel
and a relatively small number of samples are available, a dimen-
sionality problem inevitably arises.
Murphy and Mian [25] and Friedman et al. [9] initiated the use
of Bayesian network models to identify and establish generegulatory networks frommicroarray data. Bayesian network mod-
els can include most of the previously proposed discrete and con-
tinuous models as special cases and allow for hidden variables as
well as the incorporation of prior knowledge into network learn-
ing. This approach recently attracted substantial research interest
and has become the major approach for regulatory network learn-
ing [2,26,27]. Many of these recent studies explored the use of the
Bayesian networks learning framework to combine microarray
data with existing knowledge and other types of genomic data to
establish more accurate regulatory network models.
However, the number of possible structures in a Bayesian net-
work grows exponentially with respect to the number of variables,
and an exhaustive search of all possible structures becomes com-
putationally inhibitive for network structures of a moderate size.
Moreover, an exact structure-learning method is super-exponen-
tial complex with respect to the number of variables; it works well
for smaller networks. Indeed, Chickering [28] demonstrated that
learning Bayesian networks from data is NP-hard. Consequently,
other search-based methods have received a lot of attention in
the machine learning community. These include heuristic search
techniques, genetic algorithms, simulated annealing, Markov Chain
Monte Carlo (MCMC) [29], and conditional independence tests
[30]. Although, most of these methods, particularly heuristic
search techniques including greedy search and Hill climbing algo-
rithm, work reasonably well for networks of small sizes (<10
nodes), they appear to be computationally complex for networks
of moderate sizes.
As a result, a powerful approach based on the consideration of
zero- and ﬁrst-order conditional independence for model concen-
tration graphs has gained attention. This technique is suitablewhen
the number of samples is much smaller when compared to the
number of genes. Wille and Buhlmann [31] proposed to approxi-
mate the concentration graph by having the graph G01 describe
zero- and ﬁrst-order conditional independence. An edge between
the variables Xi and Xj is drawn in the graph G01 if and only if, zero-
and low-order correlations between these two variables both differ
from zero, that is if
rðYi;YjÞ – 0 and 8k 2 f1 . . . . . . ; vg n fi; jg; rðYi;YjjYkÞ– 0 ð2Þ
where r(Yi, Yj|Yk) is the partial correlation between Yi and Yj given Yk.
This procedure allows for a reduction in dimension and is able to
construct an interpretable model. This approach has also been used
by Magwene and Kim [32] and de le Fuente et al. [33] in order to
estimate undirected gene networks from microarray gene expres-
sion in the yeast Saccharomyces cerevisiae. Meanwhile, Castelo and
Roverato [34] investigated similar undirected qth order partial inde-
pendence graphs for qP 1 and presented a thorough analysis of
their properties. In this paper, we extend and use this approach
by deﬁning the qth order conditional dependence DAGs G(q) for
Bayesian network representations to infer GRNs to analyze breast
cancer metastasis.3. Materials and methods
We investigated the Bayesian network with the low-order
conditional independence extension to examine gene regulatory
processes during breast cancer metastasis. The detailed implemen-
tation of this approach is discussed below.
3.1. Bayesian network
3.1.1. Theory of graphical model associated with DAGs
The Bayesian network is a graphical model that encodes proba-
bilistic relationships among variables of interest. It consists of two
major parts: a dependency structure and local probability models.
Fig. 1. A simple Bayesian network representation that explicates relationships
between ﬁve genes.
Fig. 2. The Markov Blanket of variable A is composed of the variable’s parents, the
children and the other parents of these children. Here the Markov Blanket variables
are shown in a gray circle.
F.K. Ahmad et al. / Journal of Biomedical Informatics 45 (2012) 350–362 353The dependency structure represents a set of variables and their
probabilistic independencies. Formally, the Bayesian network is a
DAG whose nodes represent variables and whose missing edges
encode conditional independencies between variables. The second
part of this model, the local probability models, speciﬁes how vari-
ables depend on their parents. These dependencies can be repre-
sented by the Conditionality Distribution Table (CPT).
For this study, we deﬁned the Bayesian network, BN, as a pair:
BN = (G,P), where G = (X,E(G)) and is a DAG with a set of variables
(or nodes) X denoted {Xi; i 2 V}, whilst edges EðGÞ#X  X and P
correspond to joint distribution on the variables. The detailed nota-
tion of this technique is presented below:
V = {1 6 i 6 v} is the set of the observed genes; Vi = v/{i} the set
of the observed genes except gene i; X = {Xi; i2 V} the gene expres-
sion of V; G = (X, E(G)) the a DAG whose vertices are deﬁned by X
and edges by EðGÞ#X  X; eG the DAG describing the set of full-or-
der conditional independence, and G(q) is the qth order conditional
independence DAG.
We use an example to illustrate the basic idea of the Bayesian
network. Given the Bayesian network speciﬁed in Fig. 1 for ﬁve
genes: X1, X2, X3, X4, and X5, this structure speciﬁes the parents
for genes X3, X4, and X5: Pa(X3) = {X1, X2}, Pa(X4) = {X1},
Pa(X5) = {X3}, where Pa(V) represents the parent vertex set for ver-
tex V.
PaðXi;GÞ :¼ fXi such that ðXj;XiÞ 2 EðGÞ; j 2 Vg ð3Þ
Thus, the joint distribution of the node values in DAG can be written
as the product of the local distribution of each node and it parents:
PðX1; . . . . . . . . .XnÞ ¼
Yn
i¼1
PðXijparentsðXiÞÞ ð4Þ
The structure of this network also implies several conditional inde-
pendency relationships: I(X1; X2), I(X3; X4|X1), I(X5; X1, X4, X2|X3),
I(X4; X3, X5|X1), and I(X2; X1, X4), where I(X; Y|Z) denotes that X
and Y are conditionally independent given Z. In our context, it can
be interpreted that when genes in Z are at ﬁxed expression levels,
the expression levels of genes in X do not provide any information
about the expression levels of genes in Y and vice versa. Once G is
speciﬁed for a set of genes, we can interpret a directional edge from
X to Y in G as a statement that X is the ‘‘cause’’ of Y, or the expression
level of X has an effect on the expression level of Y.
3.1.2. Markov Blanket
The Markov Blanket is another important characteristic of the
Bayesian network. The Markov Blanket of a variable is the set of
variables that completely shield off this variable from the other
variables. This set consists of the variable’s parents, the children
and the other parents of these children as shown in Fig. 2. A vari-
able in a Bayesian network is conditionally independent of othervariables given its Markov Blanket. Conditional independency
means that when the Markov Blanket of a certain variable x is
known, adding the knowledge of other variables leaves the proba-
bility of x unaffected [35]. This is an essential concept because the
Markov Blanket is the only knowledge needed to predict the
behavior of that variable. To such an importance aim, this study
will focus on the Markov Blanket of the metastasis variable.
3.2. Structure learning of the Bayesian network
There are generally two approaches to establish the Bayesian
network from data: the search and the scoring methods as well
as the dependency analysis methods. The ﬁrst approach involves
searching for the best structure that ﬁts the data. Several scoring
methods have been applied, including the Bayesian scoring, entro-
py based and minimum description length. Once the scores are ob-
tained, the next step is to use search methods, such as the heuristic
search, to construct the best-ﬁt network structure. However, this
approach does not provide posterior distribution over all the
parameters of the model which is essential for sorting gene–gene
interaction.
On the other hand, the dependency analysis approach tries to
identify from the data the dependencies to construct the network
structure. This approach is generally more efﬁcient than the search
and scoring methods for high dimensionality data [36] and offers
functional interaction relationships between genes [37]. Different
forms of conditional independency (CI) tests have been used to
measure the dependency relationships. In this study, we used the
low-order conditional independence and its variants, full-order
conditional independence, which were proposed by Wille and
Buhlmann [31] to construct a GRN.
Full-order conditional independence is the exact set of edges
between the successive variables Xj and Xi, given the remaining
variables XVj, where Vj = V/{j} and XVj = {Xk; k 2 Vj} and can be de-
ﬁned as:eG ¼ ðX; fðXj;XiÞ;Xi= ? XjjXVjgi;j2V Þ ð5Þ
DAG eG is the smallest subgraph to which the probability distribu-
tion P allows for a Bayesian network representation. Reverse discov-
ery of DAG eG to model a GRN, requires determining each variable Xi
and the set of variables Xj on which variable Xi is conditionally inde-
pendent given the remaining variables XVj. However, by applying
this approach, we still face the curse of dimensionality because
the number of genes v is much greater than the number of measure-
ments in n samples. Refer to Malouche [38] for additional technical
details.
Therefore, to reduce the dimension, we estimate DAG eG by qth
order conditional independence DAGs G(q) (q < v). As needed, we
are able to extend the Bayesian network approach based on the
Fig. 3. Algorithm for proposed method Step 1: inferring G(1) and Step 2: inferring eG
from bGð1Þ .
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by Wille and Buhlmann [31] for the Gaussian graphical model
(GGM). DAGs G(q) is deﬁned as below:
8q < v ;GðqÞ ¼ ðX; fðXj;XiÞ; 8Q #Vj; jQ j ¼ q;Xi XjðXQgi;j2V Þ
8q < v ; eG#GðqÞ ð6Þ
DAGs G(q) provides an alternative way of producing dependence
relationship between variables, but it are no longer associated with
global relationship in the Bayesian network representation. Indeed,
we consider that including the qth order conditional independen-
cies better reﬂects the DAG eG, which is further illustrated in the re-
sults section.
3.3. Bayesian inference network
We applied the qth order dependence DAGs G(q), for all q < v to
construct a gene regulatory network for breast cancer metastasis.
We set qmax as the maximal number of parents in eG. Inference of
G(qmax) requires to outline, for each pair (i, j), if there exists a subset
Q #Vj of dimension qmax such that Xi\ XjXQ. For each pair (i, j),
there are qmaxv  1
 
potential sets that can lead to conditional inde-
pendence. However, testing each conditional independences given
any possible subset of qmax variables is both complex and time con-
suming. To evade these issues, we proposed to exploit an Eq. (6) to
develop an inference procedure for eG.
We introduced two steps for the Bayesian network modeling. In
the ﬁrst step, we inferred the 1st order independence. We then ap-
plied the estimated DAG bGð1Þ to obtain DAG eG. The following sub-
sections describe in detail each step utilized in this study to infer a
GRN for breast cancer metastasis.
3.3.1. Step 1: Inferring G(1)
Initially, we estimated the probability of an edge (Xj,Xi) by mea-
suring the conditional dependence between the variables Xj and Xi
given any variable Xk through partial regression coefﬁcient aij|k de-
ﬁned as follows:
Xi ¼ Mijk þ aijjkXj þ aijjkXk þ gi;j;k ð7Þ
Here the rank of matrix (Xj, Xk) equals 2 and the errors, gi,j,k are cen-
tered and have the same variance. Three M-estimators are proposed
in this study to estimate the coefﬁcient described in Eq. (7): Least
Square (LS) estimator, Huber estimator and Tukey bisquare estima-
tor. LS estimator is the most frequently used method to analyze
microarray data, while the two latter methods are identiﬁed as ro-
bust estimators [39]. We computed the estimates âij|k, for each k– j,
according to one of these estimators and derived the p-value pi,j,k
from the standard signiﬁcance test; ‘aij|k = 0’. Then, a score S1(i, j)
for each potential edge (Xi,Xj) was assigned to the Maxk–j (pi,j|k) of
p  1 computed p-values. Lastly, the inferred DAG bGð1Þ contained
the edges that were assigned a score below the chosen threshold
a1, where the smallest score indicates the most signiﬁcant edges.
This inferred network is used in the next step.
3.3.2. Step 2: Inferring eG from G(1)
In the second step, we applied the inferred network DAG bGð1Þ
obtained in Step 1 as a reduction of the search space. This approach
was possible because we knew eG#Gð1Þ (from Eq. (6)). The model
selection for eG, was carried out using standard estimation and tests
among the edges of bGð1Þ. For each set of edges (Xj,Xi) in bGð1Þ, we de-
noted by að2Þij the regression coefﬁcient,
Xi ¼ Mi þ
X
j2paðXi ;bGð1ÞÞ a
ð2Þ
ij Xj þ gi ð8Þwhere the rank of matrix ðXjÞ
j2paðXi ;bGð1ÞÞ is jpaðXi; bGð1ÞÞj and the errors,
gi are centered. We assigned to each edge of bGð1Þ, a score S2(i, j)
equal to p-value pij(2). For those edges that were not in bGð1Þ, the
score S2(i, j) = 1 was assigned. Finally, the inferred network DAG eG
was constructed and contained edges whose scores were below
the threshold a2. Parallel to Step 1, the smallest score indicated a
signiﬁcant relationship. The algorithm for these two steps is de-
scribed in Fig. 3.
3.4. Fold change and p-value analysis
Microarray technology generates thousand of gene expression
levels that can be determined from various samples, either taken
at different time instants of a biological process or under several
conditions, for instance tumor cell lines vs. normal cell lines. In
spite of producing large number of data points, the vast majority
of microarray data is non-informative. Accordingly, using dataset
to construct network model for breast cancer metastasis without
former examination will caused severe computational complexity.
Therefore, prior the downstream analysis, these gene expression
values are required to be ﬁltered in order to identify genes that
are differentially expressed in the condition being studied. While
many other possible methods has been implemented to discover
relevance genes such as t-test, Wilcoxon test and many gene selec-
tion methods, in this study, fold change and p-value analysis have
been used to determine signiﬁcant genes in two distinct groups,
good prognosis group and poor prognosis group. The key idea for
applying these combination criteria is it typically ﬁnds more bio-
logically meaningful sets of genes rather than using a single meth-
od. Fold change can be characterized as a metric used for
comparison a gene expression level between two diverse condition
such as a treatment and a control that are outside of a given cutoff
or threshold. To be precise, fold change for a gene k, Fk can be ob-
tained by quantifying the ratio between expression, E in state a
(treatment condition) and expression, E in state b (control condi-
tion) as given in the following equation:
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 
¼ log 2ðEkaÞ  log 2ðEkbÞ ð9Þ
The values of fold change can be categorized under three main as-
pects, whereby if it is greater than one for up-regulated genes, less
than one for down-regulated genes and equal to zero for unchanged
expression in both observed genes. In this study, the initial selec-
tions of signiﬁcant genes in this study were conducted similar to
work done by van’t Veer et al. [40], based on the following criteria:
 Genes with at least fold change of two (twofold increase or
decrease).
 P-value of less than 0.01 in more than three tumors.
3.5. Testing datasets
In this section, we present two types of testing datasets: an
empirical study and simulation study. In the empirical study, we
ran the proposed method on the dataset from real experiment,
whereby van’t Veer dataset was used. Whilst in the simulation
study, we generated a simulated dataset using Monte Carlo ap-
proach to test the performance of our proposed method. The fol-
lowing subsection describe in detail each of these datasets.
3.5.1. Empirical study
We tested this method using a data set of 117 breast cancer
microarray from van’t Veer et al. [40]. We retrieved these data
from the Integrated Tumor Transcriptome Array and Clinical data
Analysis database (ITTACA, 2006). This data set contains expression
proﬁle information from 20 BRCA1 and 97 lymph-node negative
breast cancer patients who are 55 years old or younger. In addition,
each patient has the following associated clinical information: age,
tumor size, histological grade, angioinvasion, lymphocytic inﬁltra-
tion, estrogen receptor (ER) and progesterone receptor (PR) status.
We restricted our analysis to the 97 sample data set, and the data
related to BRCA1 has been eliminated from this study because it
does not provide information regarding the patient’s metastasis
status. Among the remaining 97 samples, 46 developed distant
metastasis within 5 years and 51 remained metastasis free for at
least 5 years. DNA microarray analysis was used by van’t Veer to
determine the expression levels of approximately 25,000 genes
for each patient. The isolated RNA from cancerous tissues, labeling
of complementary RNA (cRNA), competing hybridization of labeled
cRNA with a reference pool of cRNA from all tumors to arrays con-
taining 24,481 gene probes, quantization and normalization of
ﬂuorescence intensities of scanned images are previously de-
scribed (van De Vijver et al. [41]). The methods described above,
along with low-order conditional independence and full-order
conditional independence was applied to this 97 sample data set.
3.5.2. Simulation study
We also tested the proposed method using simulation study.
The major issue in constructing GRN is the curse of dimensionality,
where there is thousand of genes to be analyzed compare to few
number of sample size. Implementing proposed method solely
based on the real data with such high dimensionality criteria could
caused over ﬁtting. To evade this problem, we conduct a Monte
Carlo simulation experiment to evaluate the performance of pro-
posed method. In doing so, we generated gene expression levels
with number of genes, p = 1000, and sample, n = 500. The true
expression levels for each gene Xij, where X is the gene expression
value for gene i in sample j, were randomly transformed into log
base 2 distribution, with standard deviation 1.2. In addition, we as-
sumed an equal variance for good and poor prognosis group with
rpg = rig, where pg and ig are signiﬁed for poor and good prognosis
group respectively. Technical noise intrinsic to microarray plat-
form was also added during the experiment to somewhat producea dataset that reﬂects real microarray data. The simulated data was
then divided into two groups: (1) training and (2) testing, with
each data contained 250 samples. We used training data to exam-
ine the proposed method, while testing data was applied to check
its performance. The simulation in this study was performed using
R language deﬁnition.
3.6. Validation
We evaluated the performance of the constructed network
using two different approaches. In the ﬁrst approach, we used
ROC curves and the corresponding area under the ROC curve to
measure the accuracy of the network reconstruction based on
low-order conditional independence. ROC curves display the true
positive rate (TPR) in dependence of the false positive rate (FPR).
The TPR and the FPR are determined in dependence of a prediction
threshold for the prior probabilities; edges with a probability
above the threshold are included in the network. In addition, we
quantiﬁed the predictive values of currently used clinical prognos-
tic indices: the TNM staging system [42], the St. Gallens [43], and
the NIH 2000 consensus [44], and compared their performances
with our proposed method. We further demonstrated the accuracy
corresponds with the area under the ROC curve (AUC) for all these
methods by applying the trapezoid rule:
AUC ¼ 1=2
XD
d¼1
ðTPRðdÞ þ TPRðd1ÞÞ:ðFPRðdÞ  FPRðd1ÞÞ ð10Þ
where d is the maximum possible number of edges constructed in a
breast cancer GRN. If a prediction has an accuracy of 0.5, it means
that on average the prediction cannot distinguish between true
and false edges, and is therefore not useful in inferring breast cancer
metastasis. We performed this evaluation by using the ROCR
package.
In the second approach, we used mean square error (MSE) as an
indicator to illustrate that our proposed method correctly esti-
mates gene relationships and can handle large amount of genes
with minimum error. We applied approximately two-thirds of
the data set to train the algorithm and to construct the gene net-
work and one-third of the data set to test the MSE. The MSE is ex-
pressed as:
MSE ¼ 1=P
XP
p¼1
ðRip  RipÞ ð11Þ
where Rip is the desired inference, Rˇip is the obtained inference of
output unit i for input gene-interaction pattern p, and P is the total
number of gene interaction patterns in the data set below the
threshold a.
4. Results and discussion
4.1. Gene-regulatory network
To obtain insights into the mechanism of gene regulation and
how gene mutations act to turn on tumor development and metas-
tasis progression in a cellular network context, we ran the pro-
posed method on the breast cancer data set, producing a GRN as
shown in Fig. 4. See Additional ﬁle 1 shows the p-value of the con-
ditional independence test between the transcription regulatory
genes and their co-expressed genes, which is illustrated in Fig. 4.
The learned regulatory relationship for breast cancer prognosis
was constructed with a threshold of a = 0.01. This learned network
reveals a group of genes which are primarily associated with caus-
ing metastasis, M. The larger nodes in the graph specify the genes
when expressed at different levels lead to a major effect on the
Fig. 4. The complete GRN for breast cancer metastasis using the low-order conditional independence method.
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nodes denote the highly regulated genes. Four genes that are found
to regulate the expression levels of other genes are: BBC3, GNAZ,
TSPY-like 5 (TSPY5), and DCK. Two genes are highly regulated:
FLJ11354 and CCNE2. This GRN involved 50 genes associated with
metastasis, M, and 39 of them are annotated.
The constructed GRN indicates that the BBC3 gene has a prom-
inent role in regulating others genes. Eight genes are correlated
with BBC3. The BBC3 gene, also known as PUMA is located on hu-
man chromosome 19q13.3-q13.4 and is homologous with a Bcl2
family member. The biological role for BBC3 is to induce apoptosis
via the mitochondrial apoptotic pathway. Furthermore, BBC3 is
also transcriptionally activated by the tumor suppressor p53,
which is a key regulator of apoptosis and tumorigenesis in breast
cancer. The expression of BBC3 was observed in human cancer
cells, which associate with p53 in several studies [45,46], and re-
cently this gene has been reported to contribute to the transduc-
tion of diverse cell deaths and metastasis status [47]. On the
other hand, the protein encoded by the gene GNAZ (AI847979,
Gz) is a guanine nucleotide-binding protein, and these proteins
are also known as modulators or transducers of various transmem-
brane signaling systems. GNAZ may also play a role in maintaining
the ionic balance of perilymphatic and endolymphatic cochlear ﬂu-
ids. Although, there is insufﬁcient information about whether
GNAZ could directly regulate the progression of breast cancer, we
discovered that it has an essential role in cellular processes of
the nervous system [48].
TSPY-like 5 (TSPYL5), also known as KIAA1750, is involved in
nucleosome assembly, a process which, if destabilized, can alter
the regulatory mechanisms of a cell and is therefore likely to occur
during cancer. TSPYL5 has been identiﬁed as a genetic marker for
breast cancer in several studies [49,50]. In addition, it has been
noted to play a role in the circulation of luteinizing hormone
(LH) [51], which is known to prompt tumor growth in breasts
[52]. Our last genetic regulator is Deoxycytidine kinase (DCK).
The DCK gene is required for the phosphorylation of several deoxy-
ribonucleosides and their nucleoside analogs. Deﬁciency of DCK is
associated with resistance to antiviral and anticancer chemothera-
peutic agents, therefore this gene is clinically important because ofits relationship to drug resistance and sensitivity. The DCK gene
has been used to study resistance to chemotherapy in myeloid leu-
kemia (AML) [53] and breast cancer patients [54] and was active in
sporadic breast cancer [55]. In addition, this particular gene may
catalyze the metabolic activation of gemcitabine, a drug that has
been used to treat several different types of cancer [56].
Outside of these regulator genes, two additional highly regu-
lated genes have been identiﬁed in the analysis of our proposed
method: FLJ11354 and CCNE2. The FLJ11354 gene was discovered
by Sun et al. [57], however the exact function of this gene is still
unknown. Meanwhile, CCNE2 encodes a protein similar to cyclin
that acts as regulators of Cyclin Dependent Kinase (CDK). Different
cyclins exhibit distinct expression and degradation patterns and
contribute to the temporal coordination of each mitotic event. This
particular cyclin forms a protein complex and functions as a regu-
latory subunit of CDK2 to play a role in G1/S transition in the cell
cycle. The expression of this gene peaks at the G1-S phase and
exhibits a tissue-speciﬁc expression pattern distinct from cyclin
E1. A signiﬁcant increase in the expression level of this gene was
observed in tumor derived cells. CCNE2 has also been reported to
qualify as independent prognostic markers for lymph node–nega-
tive breast cancer patients [58] and appears to have a predictive
value in ER positive cases among breast cancer patients [59].
4.2. Markov Blanket
The identiﬁcation of genes that regulate breast cancer metasta-
sis has been the subject of intense investigation. To accomplish
this, we derived the metastasis variable, M and its Markov Blanket
as shown in Fig. 5 from a GRN. This result is comprehensively pre-
sented with the gene names applied where possible. Six genes have
been identiﬁed to be signiﬁcant in regulating tumor progression in
breast cancer: PK428, MS4A7, MMP9, TSPYL5, FJ12443, and Con-
tig32125_RC. Two genes are highly regulated, one of them is cyclin
E2 (CCNE2). These two regulated genes have three other corre-
sponding parents, attached to them.
MMP9, PK428, TSPYL5 and CCNE2 have been identiﬁed as pre-
valent genes that regulate breast cancer metastasis, whereas
MS4A7, FJ12443 and Contig32125_RC remain unexplained. A
Fig. 5. The Markov Blanket for breast cancer metastasis with ﬁve annotated and
one undeﬁned gene regulators.
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mor progression in breast cancer [60,61]. It appears that most
MMPs, as in the case of MMP-9, play an important role even in
the early stages of carcinogenesis, prior to basement membrane
degradation. MMPs are also implicated in cell growth via the acti-
vation of mitogenic factors, remodeling, angiogenesis and selection
of apoptosis-resistant cells [62].
PK428 is a gene that belongs to the Serine/Threonine protein ki-
nase family. It is also known as CDC42BPA. This gene has been re-
ported to be related to a risk of polymorphism [63] and isTable 1
Biological processes identiﬁed from GO for gene regulators obtained using the proposed m
Biological process Functions
Nucleosome assembly Nucleosome assembly
Catabolic process Collagen catabolic process
Ketone body catabolic process
Ubiquitin-dependent protein catabolic process
Proteolysis
Apoptotic program Positive regulation of apoptosis
Induction of apoptosis
DNA damage
Extracellular matrix Extracellular matrix organization and biogenesis
Signal transduction Intracellular signaling cascade
Signal transduction
Intracellular signaling cascade, rho protein signal tra
Neuropeptide signaling pathway
G-protein coupled receptor protein signaling pathwa
Biosynthetic process Phospholipid biosynthetic process
Positive regulation of collagen biosynthetic process
Cell development Cell cycle phase, cell morphogenesis
Cell growth
Multicellular organismal development
Cell cycle, cell division
Cell cycle, cell division, mitosis
DNA metabolic process DNA replication
Positive regulation of DNA replication
Negative regulation of DNA replication
Metabolic process
Transcription regulation
Pyrimidine nucleotide metabolic process
Transport Sugar transport
Hormone stimulus Menstrual cycle phase
Response to progesterone stimulus
Response to estrogen stimulus
Other processes Macrophage differentiation
Establishment of blood-nerve barrier
Protein amino acid phosphorylationassociated with breast cancer progression [64]. Although the role
of this gene in breast cancer metastasis is still moderately con-
cealed, we have noticed its contributions toward cell migration,
which is essential in tumor progression [65]. TSPYL5, on the other
hand, has been regarded as the most outstanding marker by Wang
et al. [66]. The detailed involvement of the TSPYL5 and the CCNE2
genes in breast cancer metastasis is highlighted in the previous
section.
We further determined the biological relevance of the identiﬁed
gene regulators for breast cancer metastasis using the Gene Ontol-
ogy (GO) descriptions. We were interested to explore the biological
processes, as gene function is much more complex, and crucial in
understanding the events of initiation, transformation and metas-
tasis of breast cancer cells. Table 1 shows that all of the gene reg-
ulators identiﬁed by the proposed method are classiﬁed into
eleven very speciﬁc categories of biological processes. Signal trans-
duction, cell development and the DNA metabolic process reached
the maximum number of genes, compare to other biological pro-
cesses, with ﬁve genes respectively grouped into each process.
These biological processes are reported in the literature to have a
major involvement in breast cancer metastasis and tumor progres-
sion [67,68]. Current evidence also suggests that targeting of sig-
naling molecules and cell cycle related genes is a promising new
approach to infer the mechanism of gene regulation in cancer
and is consequently used in the treatment of breast cancer.4.3. The validation and assessment of network inference methods
4.3.1. Empirical evaluations
Learned regulatory networks produced from real experimental
data are typically difﬁcult to evaluate, partly because large por-
tions of the underlying true network remain unknown. Withoutethod with a threshold <0.5.
Number of genes Components Threshold <
1 TSPY-like 5 0.01
4 MMP9 0.01
OXCT1 0.05
UCH37 0.05
PITRM1 0.05
3 MMP9 0.01
TGFB3 0.03
L2DTL 0.03
1 MMP9 0.01
5 CDC42BPA 0.01
MS4A7 0.01
nsduction ECT2 0.02
GPR126 0.04
y GNAZ 0.05
2 LPCAT1 0.01
TGFB3 0.03
5 ECT2 0.02
TGFB3 0.03
SEMA3F 0.03
CCNE2 0.03
HEC 0.04
5 L2DTL 0.03
TGFB3 0.03
TGFB3 0.03
GSTM3 0.03
EBF4 0.05
DCK 0.05
1 SLC2A3 0.02
2 TGFB3 0.03
TGFB3 0.03
GSTM3 0.03
MMP9 0.01
GSTM3 0.03
STK32B 0.04
Low-order (LS)
Low-order (Tukey) 
Low-order (Huber) 
Full-order (LS)
Full-order (Tukey) 
Full-order (Huber) 
Fig. 6. The AUC for three different estimators.
Fig. 7. Number of TP at FP = 30.
Low-order CI 
Full-order CI 
Fig. 8. Number of extra edges.
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choice is to employ a quantitative assessment to measure the qual-
ity of the reconstruction network. In our study, we used ROC to
evaluate the learned regulatory network that had been constructed
using the proposed methods. The ROC curve describes the trade-off
between sensitivity (true positive rate) and the speciﬁcity (1-false
positive rate). After the selection of 5000 genes using fold change
analysis and p-value, these genes were evaluated in term of AUC.
Fig. 6 presents the AUCs for the developed methods with different
estimators at various numbers of genes. From this diagram, it
shows that the AUC of low-order conditional independence outper-
formed full-order for almost every estimator. It is also interesting
to note that this technique works well with the increasing number
of genes whereas full-order which was developed using Huber andTable 2
The accuracy of proposed method.
Method Number of genes N
Low-order conditional independence 5000 3
Full-order conditional independence 5000 2Tukey estimators decreased when the numbers of genes exceed
500. The result indicates that full-order conditional independence
is merely stable for small number of genes however as the amount
of variables increase, their performances tend to declined. This
could attributed to the large number of pairs involved in the gene
network which require to be examined and has eventually de-
crease the performance of full-order conditional independence. It
is also discovered that LS estimator show better AUC results rela-
tive to Tukey and Huber estimators in both cases (low-order and
full-order conditional independence).
To examine the structure prediction, the predicted graphs are
tested in term of true edges. Fig. 7 illustrated the results of TP at
ﬁxed FP. TP is the correctly identiﬁed true edges that were able
to predict in all the cases. Low-order conditional independence
was found comparatively better than full-order conditional inde-
pendence at number of genesP1000. It shows that low-order con-
ditional independence can predict highest number of true edges
with reasonable number of FP. In contrast, at small number of vari-
ables (6500), full-order conditional independence shows slightly
better performance than low-order conditional. This denotes to
computational power of full-order conditional independence,
whereby it produces better results when the number of genes is
smaller.
Besides looking at TP, Table 2 shows the accuracy of proposed
method. In this test, a range of number of genes is examined to
seek the effectives in handling large number of genes in a small
sample size. As explained in earlier, the main issue in GRN is to
cope with large number of genes in very small observation
(n p). Therefore, accuracy test is carried out for diverse number
of genes. The tabulated results given in Table 2 signiﬁes that pro-
posed methods work efﬁciently. For the number of genes = 5000,
the low-order conditional independence recovered almost 81% of
test edges whereas full-order conditional independence predict
approximately 79%. The low-order and full-order conditional inde-
pendence also have achieved a larger number of edges (303 and
280). This result shows the inherent advantages of proposed meth-
od in better detecting high-conﬁdence edges.umber of edges TP edges (test edges) Accuracy (%)
03 245 81.3
80 220 78.6
Low-order CI 
Full-order CI 
Fig. 9. Number of missing edges.
Low-order CI 
Full-order CI 
Fig. 10. Number of MSE at different number of genes.
Fig. 11. ROC for clinical indices.
Fig. 12. The true positive (TP) rate is plotted against the false positive (FP) rate for a
given cutoff value for three diverse methods to infer breast cancer metastasis.
Table 3
The AUC performance and the standard deviation of the ﬁve methods used for the
inference of breast cancer metastasis are given. The ﬁrst three methods (NIH2000,
TNM staging system and St. Gallen) are included for comparison. The next two
methods (low-order conditional independence and full-order conditional indepen-
dence) refer to the proposed methods to construct a GRN for breast cancer inference.
Methods AUC Std
NIH2000 0.61905 0.16234
TNM staging system 0.71429 0.12747
St. Gallen 0.73810 0.36204
Low-order conditional independence (70 gene
signatures)
0.79203 0.03245
Full-order conditional independence (70 gene
signatures)
0.76438 0.02928
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dence produced less number of edges and generated less missing
edges in contrast to full-order conditional independence at all dif-
ferent amount of genes. This is apparently because the high-order
conditional independence was not performed in this method. Al-
beit, full-order conditional independence has demonstrates some-
what remarkable decline on both elements (extra and missing
edges) with increasing genes number.
Learning the structure of the Bayesian network from data sub-
ject is NP-hard. Therefore further assessment on the quality of
the low-order conditional independence method is performed by
examining its ability to correctly reconstruct the optimal structure
of the gene regulatory process with a large number of variables and
a deﬁcient samples size: 97 cases of breast cancer metastasis. In
this study MSE has used as an indicator to demonstrate that the
proposed method is capable of obtaining correctly estimate gene
relationships and can handle large amount of genes with minimum
error. The smaller value of MSE indicates an optimum network
structure. Fig. 10 shows the MSE of inferred network obtained by
using low-order and full-order conditional independence with5000 genes at threshold a 6 0.01. Note that at (d) the low-order
conditional independence is lower than full order conditional
independence.
Table 4
Simulation study on low-order and full-order conditional independence.
GRN model Sample size No. of genes Low-order conditional independence Full-order conditional independence
No. of edges Accuracy (%) No. of edges Accuracy (%)
G1 50 250 105 70 95 75
G1⁄ 97 67 80 70
G2 100 500 125 73 100 68
G2⁄ 100 70 94 63
G3 250 1000 180 82 140 72
G3⁄ 120 80 100 70
Average 73.67 69.67
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proposed method are tied up around the number of genes involved
in order to construct GRN. To further access the reliability of the
proposed method, this study has compared it performance against
clinical indices. St. Gallen, TNM staging system and NIH 2000 are
some of the most prominent breast cancer indices. The application
of these indices is widely accepted and used by oncologist to pre-
dict breast cancer metastasis and test the aggressiveness of tumor
cells. For such a reason, these indices are employed to give a better
picture of how well the proposed method works. At ﬁrst, classiﬁca-
tions of these indices are developed using Naïve Bayes in R envi-
ronment (package e1071). The corresponding ROC curves for
these indices are plotted as shown in Fig. 11. Later, the preeminent
index is compared with the proposed methods.
It was observed that the St. Gallen criterion has signiﬁcantly
outperformed both the TMN staging system and the NIH 2000 con-
sensus, whereas the latter approach (the NIH 2000 consensus) was
worse than the TNM staging system. By adopting the study of van’t
Veer et al. [40], the sensitivity was set equal to 90%. The St. Gallen
criterion achieved 43% speciﬁcity meanwhile the TNM staging sys-
tem and the NIH 2000 consensus have obtained a speciﬁcity of 18%
and 0%, respectively. It is interesting to note that estimation made
in this study (the speciﬁcity of the St. Gallen criterion outperforms
the TNM staging system) is consistent with previous ﬁnding [69].
However, speciﬁcity of the TNM staging system is better than the
NIH 2000 consensus is counterintuitive. This may be due to unbal-
anced data between the good and the poor prognosis groups in the
testing dataset.
Based on the result obtained earlier, the predictive values of the
St. Gallen criterion is compared to the low-order and full-order
conditional independence methods as shown in Fig. 12. In this case
the proposed method was run on 70 genes which were discovered
as gene signatures by van’t Veer et al. [40]. This is essential step to
eliminate any bias toward gene expression proﬁles. Both methods
have been computed using the Least-Square estimator, which has
outperformed compared to Huber and Tuckey estimators in the
early validation (Fig. 6). The low-order conditional independence
has performed better than the St. Gallen criterion and the full-or-
der conditional independence. At the identical level of sensitivity
(90%), low-order conditional independence attained 53% speciﬁc-
ity. This result is parallels to follow-up validation study from on
a larger dataset van De Vijver et al. [41].
In addition, Table 3 shows the AUCs for the various methods
where a higher AUC indicates better reconstruction accuracy. The
low-order conditional independence method performs the best of
the ﬁve methods by this measure (highest AUC), suggesting that it
produces a better prediction model. The other methods have some-
what poorer result than the full-order conditional independence
method, with the NIH2000 consensus appearing to have the least
accuracy. Both proposedmethods also have smaller standard devia-
tions (std) when compared to other methods, which yields an even
more accurate inference of the GRN for breast cancer metastasis.4.3.2. Simulation evaluations
GRNwas also constructed using a simulated data. Table 4 shows
three different GRN models that were developed, namely G1, G2
and G3. Each of these implementation were tested on different data
and the results is presented in G1⁄, G2⁄ and G3⁄ respectively. We
have randomly chosen different sample size to test our proposed
method with diverse number of genes. The results show that low-
order conditional independence achieved better average accuracy
compared to full-order conditional independence, with 73.67%.
However, it is interesting to note that in G1 and G2 both methods
were roughly present similar performance. As the number of genes
increased in G3, we observed that low-order conditional indepen-
dence method signiﬁcantly obtained higher accuracy in relative to
full-order conditional independence method. These results proved
that low-order conditional independencemethod is suitable to con-
struct large scale GRN from microarray data.5. Conclusion
In this study, we investigated the GRN that regulates breast can-
cer metastasis based upon the Bayesian inference network. We
examined two methods to establish the structure learning for a
large number of genes within a small sample size of a breast cancer
data set: low-order conditional independence and full-order condi-
tional independence. The constructed network using low-order
conditional independence appears to provide modest improve-
ments in GRN inference relative to full-order conditional indepen-
dence. Four overrepresented genes, BBC3, GNAZ, TSPY-like 5
(TSPY5), and DCK, were identiﬁed in this study and attest breast
cancer progression. Our Markov Blanket result indicates that
MMP9, PK428, TSPYL5 and CCNE2 are prominent regulatory genes
during breast cancer metastasis. Most of these genetic regulators
are related to the biological processes of signal transduction and
cell cycle, which currently appear to be prevalent processes in the
prediction of breast cancer metastasis. While the goal of this study
is to identify genes that regulate breast cancer metastasis, it has
been proven to be difﬁcult to examine these relationships because
there is currently no true independent network to verify such
breast cancer inference. Our quantitative evaluation has shown that
the Bayesian inference network with low-order conditional inde-
pendence outperformed the speciﬁcity of existing clinical indices
and full-order conditional independence by 10% and 30% respec-
tively. In addition, this method yields the least MSE as the number
of genes expands, which provides an alternative way to include
additional information for better inference results. We also have
tested our proposedmethod on simulated data to evade over ﬁtting.
The results have proved that low-order conditional independence
performed better than full-order conditional independence. An
important future direction is to determine the inference of a GRN
for breast cancer metastasis with integrated data and to examine
the robustness of the inference network with different data sets.
F.K. Ahmad et al. / Journal of Biomedical Informatics 45 (2012) 350–362 361The comparison of different learning algorithms such as ARACNE is
also essential in assessing the performance of proposedmethod and
identifying the most ideal method to infer breast cancer metastasis,
given all the available information and a small sample sizes num-
ber. In addition, the number of false positive and false negative
can also be evaluated to determine the optimum topology. Further-
more, future endeavors attempt to compare the performance of
proposed method against score and search approach, for instance
by using heuristic search and Bayesian scoring methods. These
studies are currently ongoing in our laboratory.
Acknowledgment
We thank Professor Dr. Hassane Bouzahir and Dr. Nor IdayuMa-
hat for useful suggestions and discussions.
Appendix A. Supplementary material
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.jbi.2011.11.015.
References
[1] Weigelt B, Peterse JL, van’t Veer LJ. Breast cancer metastasis: markers and
models. Nat Rev Cancer 2005;5:591–602.
[2] Pe’er D, Regev A, Elidan G, Friedman N. Inferring subnetworks from perturbed
expression proﬁles. Bioinformatics 2001;17:S215–24.
[3] D’haeseleer P, Wen X, Fuhrman S, Somogyi R. Linear modeling of mRNA
expression levels during CNS development and injury. In: Proceedings of the
paciﬁc symposium on biocomputing, vol. 99; 1999. p. 41–52.
[4] Mccormick F. Signaling networks that cause cancer. Trends Cell Biol
1999;9:M53–6.
[5] Vermeulen K, Bockstaele DRV, Berneman ZN. The cell cycle: a review of
regulation, deregulation and therapeutic targets in cancer. Cell Proliferat
2003;36:131–49.
[6] Arkin AP, Shen PD, Ross J. Deduction of a complex reaction mechanism from
measured time series: veriﬁcation of the theory of statistical construction.
Science 1997;277:1275.
[7] Chen R, Sivakumar K, Kargupta H. Collective mining of Bayesian networks from
distributed heterogeneous data. Knowl Inform Syst 2004;6:164–87.
[8] Wessels L, Someren EV, Reinders M. A comparison of genetic network models.
In: Proceedings of the paciﬁc symposium on biocomputing; 2001.
[9] Friedman N, Linial M, Nachman I, Pe’er D. Using Bayesian networks to analyze
expression data. J Comput Biol 2000;7:601–20.
[10] Zou M, Conzen SD. A new dynamic Bayesian network (DBN) approach for
identifying gene regulatory networks from time course microarray data.
Bioinformatics 2005;21:71–9.
[11] Huanga S, Ernbergb I, Kauffman S. Cancer attractors: a systems view of tumors
from a gene network dynamics and developmental perspective. Semin Cell
Develop Biol 2009.
[12] Beal MJ, Falciani FL, Ghahramani Z, Rangel C, Wild D. A Bayesian approach to
reconstructing genetic regulatory networks with hidden factors.
Bioinformatics 2005;21:349–56.
[13] Yavari F, Towhidkhah F, Gharibzadeh S. Gene regulatory network modeling
using Bayesian networks and cross correlation. In: Biomedical engineering
conference (CIBEC) 2008, Cairo; 2008.
[14] Liu B, de le Fuente A, Hoeschele I. Gene network inference via structural
equation modeling in genetical genomics experiments. Genetics
2008;178:1763–76.
[15] Noman N, Iba H. Inferring gene regulatory networks using differential
evolution with local search heuristics. Comput Biol Bioinform 2007;4:634–47.
[16] Hache H, Lehrach H, Herwig R. Reverse engineering of gene regulatory
networks: a comparative study. EURASIP J Bioinform Syst Biol 2009:1–12.
[17] Ahmad FK, Deris S, Othman NH. Toward integrated clinical and gene-
expression proﬁles for breast cancer prognosis: a review paper. Int J
Biometrics Bioinform 2009;3:31–47.
[18] Lewis R. Human genetics: concepts and applications. 3rd ed. McGraw-Hill;
1999.
[19] Somogyi R, Sniegoski SA. Modeling the complexity of genetic networks:
understanding multigenic and pleiotropic regulation. Complexity
1996;1:45–63.
[20] Liang S, Fuhrman S, Somogyi R. REVEAL, a general reverse engineering
algorithm for inference of genetic network architectures. In: Proceedings of
the paciﬁc symposium on biocomputing; 1998. p. 18–29.
[21] Mjolsness E, Mann T, Castano R, Wold B. From coexpression to coregulation: an
approach to inferring transcriptional regulation among gene classes from
large-scale expression data. Neural Inform Process Syst 1999;12:928–34.
[22] Mjolsness E, Sharp DH, Reinitz J. A connectionist model of development. J
Theor Biol 1991;152:429–54.[23] Wahde M, Hertz J. Coarse-grained reverse engineering of genetic regulatory
networks. Biosystems 1999;55:129–36.
[24] Jong HD. Modeling and simulation of genetic regulatory systems: a literature
review. J Comput Biol 2002;9:67–103.
[25] Murphy K, Mian S. Modeling gene expression data using dynamic Bayesian
networks. In: 1999 Computer science division. Berkeley: University of
California.
[26] Imoto S, Higuchi T, Goto T, Tashiro K, Kuhara S, Miyano S. Estimating gene
networks by Bayesian networks from microarrays and biological knowledge.
In: Proceedings of the 11th int conf on intelligent systems for molecular
biology; 2003.
[27] Hartemink AJ, Gifford DK, Jaakkola TS, Young RA. Combining location and
expression data for principled discovery of genetic regulatory network models.
In: Proceedings of the paciﬁc symposium on biocomputing; 2002. p. 437–49.
[28] Chickering D. Learning Bayesian networks is NP-complete learning from data.
In: Artiﬁcial intelligence and statistics. Springer; 1996. p. 121–30.
[29] Castelo R, Kocka T. On inclusion-driven learning of Bayesian networks. J Mach
Learn Res 2003;4:527–74.
[30] Campos Ld, Huete J. A new approach for learning belief networks using
independence criteria. Int J Approx Reason 2000;24:11–37.
[31] Wille A, Buhlmann P. Low-order conditional independence graphs for inferring
genetic networks. Stat Appl Genet Mol Biol 2006;4.
[32] Magwene PM, Kim J. Estimating genomic coexpression networks using ﬁrst-
order conditional independence. Genome Biol 2004;5.
[33] de le Fuente A, Bing N, Hoeschele I, Mendes P. Discovery of meaningful
associations in genomic data using partial correlation coefﬁcients.
Bioinformatics 2004;20:3565–74.
[34] Castelo R, Roverato A. Graphical model search procedure in the large p and
small n paradigm with applications to microarray data. J Mach Learn Res
2006;7:2621–50.
[35] Korb K, Nicholson A. Bayesian artiﬁcial intelligence. Boca Raton,
Florida: Chapman and Hall; 2004.
[36] Cheng J, Greiner R, Kelly J, Bell D, Liu W. Learning Bayesian networks from
data: an information-theory based approach. J Artif Intell 2002;137:43–90.
[37] Qiu P, Wang ZJ, Liu KJR, Hu ZZ, Wu CH. Dependence network modeling for
biomarker identiﬁcation. Bioinformatics 2007;23:198–206.
[38] Malouche D. Determining full conditional independence by low order
conditioning. Bernoulli J 2009;15:1179–89.
[39] Fujita A, Sato JR, Garay-Malpartida HM, Morettin PA, Sogayar MC, Ferreira CE.
Time-varying modeling of gene expression regulatory networks using the
wavelet dynamic vector autoregressive method. Bioinformatics
2007;23:1623–30.
[40] van’t Veer LJ et al. Gene expression proﬁling predicts clinical outcome of breast
cancer. Nature 2002;415:530–6.
[41] van De Vijver M et al. A gene-expression signature as a predict of survival in
breast cancer. New Engl J Med 2002;347:1999–2009.
[42] Benson JR. The TNM staging system and breast cancer. Lancet Oncol
2003;4:56–60.
[43] Hebert-Croteau N et al. A validation study of the St. Gallen consensus
classiﬁcation of node-negative breast cancer. Proc Am Soc Clin Oncol
2003;22:104.
[44] National Institutes of Health. Adjuvant therapy for breast cancer, NIH
consensus statement, vol. 17; 2000. p. 1–23.
[45] Lacroix M, Toillon RA, Leclercq G. p53 and breast cancer, an update. Endocr
Relat Cancer 2006;13:293–325.
[46] Han Jw, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ, et al.
Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell
death and survival signals. Proc Natl Acad Sci 2001;98:11318–23.
[47] Villarroel ES, Gutierrez J, Risueño C, Gonzalez P, Solis L, Corvalan A. Down-
regulation of bbc3, ﬂt1 and gstm3 is associated with lymph node metastases in
breast carcinoma. J Clin Oncol 2007;25:21171.
[48] Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for
representation and analysis of molecular networks involving diseases and
drugs. Nucl Acids Res 2009:1–6.
[49] Alexe G, Alexe S, Axelrod DE, Bonates TO, Lozina, Reiss M, et al. Breast cancer
prognosis by combinatorial analysis of gene expression data. Breast Cancer Res
2006;8:R41.
[50] Sun Y, Goodison S, Li J, Liu L, Farmerie W. Improved breast cancer prognosis
through the combination of clinical and genetic markers. Bioinformatics
2007;23:30–7.
[51] Yadav VK, Muraly P, Medhamurthy R. Identiﬁcation of novel genes regulated
by LH in the primate corpus luteum: insight into their regulation during the
late luteal phase. Mol Human Reprod 2004;10:629–39.
[52] Powell BJ et al. Luteinizing hormone signaling and breast
cancer: polymorphisms and age of onset. J Clin Endocrinol Metab
2003;88:1653–7.
[53] van de Heuvel-Eibrink M, Wiemer EAC, Kuijpers M, Pieters R, Sonneveld P.
Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with
relapsed and/or refractory acute myeloid leukemia (AML). Leukemia
2001;15:855–67.
[54] Shimizu D, Ishikawa T, Ichikawa Y, Toga S, Hayasizaki Y, Okazaki Y, et al.
Current progress in the prediction of chemosensitivity for breast cancer. Breast
Cancer 2004;11:42–8.
[55] Rodriguez C, Hughes-Davies L, Valle‘s Hln, Orsetti Ba, Cuny M, Ursule L, et al.
Ampliﬁcation of the BRCA2 pathway gene EMSY in sporadic breast cancer is
related to negative outcome. Clin Cancer Res 2004;10:5785–91.
362 F.K. Ahmad et al. / Journal of Biomedical Informatics 45 (2012) 350–362[56] Kocabas NA et al. Gemcitabine pharmacogenomics: deoxycytidine kinase and
cytidylate kinase gene resequencing and functional genomics. Drug Metab
Dispos 2008;36:1951–9.
[57] Sun Y, Urquidi V, Goodison S. Derivation of molecular signatures for breast
cancer recurrence prediction using a two-way validation approach. In: Breast
cancer research treatment. Netherlands: Springer; 2009.
[58] Sieuwerts AM, Maxime P, Look M, van Gelder EM, Timmermans M, Trapman
AAC, et al. Which cyclin E prevails as prognostic marker for breast cancer?
Results from a retrospective study involving 635 lymph node negative breast
cancer patients. Clin Cancer Res 2006;12:3319–28.
[59] Sotiriou C, Paesmans M, Harris A, Colozza MA, Fox S, Taylor M, et al. J Clin
Oncol 2004;22.
[60] Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, et al.
Circulating MMP2 and MMP9 in breast cancer – potential role in classiﬁcation
of patients into low risk, high risk, benign disease and breast cancer categories.
Int J Cancer 2006;119:1403–11.
[61] Scorilas A, Karameris A, Arnogiannaki N, Ardavanis A, Bassilopoulos P, Trangas
T. Overexpression of matrixmetalloproteinase-9 in human breast cancer: a
potential favourable indicator in node-negative patients. Brit J Cancer
2001;84:1488–96.
[62] Werb Z, Vu TH, Rinkenberger JL, Coussens LM. Matrix degrading
proteases and angiogenesis during development and tumor formation.
APMIS 1991;107.[63] Wang E et al. Association of genetic variation in mitotic kinases with breast
cancer risk. Breast Cancer Res Treat 2009.
[64] Yu JX, Sieuwerts AM, Zhang Y, Martens JW, Smid M, Klijn JG, et al. Pathway
analysis of gene signatures predicting metastasis of node-negative primary
breast cancer. BMC Cancer 2007;7:1–14.
[65] Wang W, Goswami S, Sahai E, Wyckoff JB, Segall JE, Condeelis JS. Tumor cells
caught in the act of invading: their strategy for enhanced cell motility. Trends
Cell Biol 2005;15:138–45.
[66] Wang X, Gotoh O. Accurate molecular classiﬁcation of cancer using simple
rules. BMC Med Genom 2009;2:1–23.
[67] Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells.
Nat Rev Cancer 2002;3:55–63.
[68] Liu J, Campen A, Huang S, Peng SB, Ye X, Palakal M, et al. Identiﬁcation of a
gene signature in cell cycle pathway for breast cancer prognosis using gene
expression proﬁling data. BMC Med Genom 2008;1:1–12.
[69] Lohrisch C, Jackson J, Jones A, Mates D, Olivotto IA. Relationship between
tumor location and relapse in 6781 women with early invasive breast cancer. J
Clin Oncol 2000;18:2828–35.
[70] Kelemen A, Abraham A. Computational intelligence in bioinformatics. Berlin:
Springer-Verlag; 2008.
[71] Margolin A, Nemenman I, Basso K, Wiggins C, Stolovitzky G, Favera RD, et al.
ARACNE: an algorithm for the reconstruction of gene regulatory networks in a
mammalian cellular context. BMC Bioinform 2006;7:S7.
